Supreme Court of the United States
Skip Navigation LinksHome | Search Results


Docket for 15-1195
No. 15-1195
Vide 15-1039
Title:
Amgen Inc., et al., Petitioners
v.
Sandoz Inc.
Docketed:March 23, 2016
Lower Ct:United States Court of Appeals for the Federal Circuit
  Case Nos.:(2015-1499)
  Decision Date:July 21, 2015
  Rehearing Denied:October 16, 2015
Questions Presented

~~~Date~~~ ~~~~~~~Proceedings  and  Orders~~~~~~~~~~~~~~~~~~~~~
Mar 21 2016 Petition for a writ of certiorari filed. (Response due April 22, 2016)
Apr 18 2016 Order extending time to file response to petition to and including May 17, 2016.
May 17 2016 Brief of respondent Sandoz Inc. in opposition filed.
May 27 2016 Reply of petitioners Amgen Inc., et al. filed.
May 31 2016 DISTRIBUTED for Conference of June 16, 2016.
Jun 20 2016 The Solicitor General is invited to file a brief in this case expressing the views of the United States.
Dec 7 2016 Brief amicus curiae of United States filed. VIDED.
Dec 20 2016 Supplemental brief of petitioners Amgen Inc., et al. filed. VIDED.
Dec 21 2016 DISTRIBUTED for Conference of January 6, 2017.
Jan 9 2017 DISTRIBUTED for Conference of January 13, 2017.
Jan 13 2017 Petition GRANTED. The petition for a writ of certiorari in No. 15-1039 is granted. The cases are consolidated and a total of one hour is allotted for oral argument.
Jan 25 2017 The following briefing schedule is adopted: Petitioner in No. 15-1039 will file an opening brief limited to the question presented in its petition, not to exceed 15,000 words, on or before Friday, February 10, 2017. Petitioners in No. 15-1195 will file a consolidated opening brief on the question presented in their petition and response brief, not to exceed 19,000 words, on or before Friday, March 10, 2017. Petitioner in No. 15-1039 will file a consolidated response brief and reply brief, not to exceed 10,000 words, on or before Friday, March 31, 2017. Petitioners in No. 15-1195 will file a reply brief, not to exceed 6,000 words, on or before Friday, April 14, 2017. Any brief of an amicus curiae in support of petitioner in No. 15-1039 or in support of neither party is to be filed on or before Friday, February 17, 2017, and the brief should bear a light green cover. Any brief of an amicus curiae in support of petitioners in No. 15-1195 is to be filed on or before Friday, March 17, 2017, and the brief should bear a dark green cover. An amicus curiae may file only a single brief in these cases. VIDED.
Jan 30 2017 Joint motion of the parties to dispense with printing the joint appendix filed. VIDED.
Feb 17 2017 SET FOR ARGUMENT ON Wednesday, April 26, 2017. VIDED.
Feb 17 2017 Brief amici curiae of Apotex Inc. and Apotex Corp. filed. VIDED.
Feb 17 2017 Brief amicus curiae of Coherus Biosciences, Inc. filed. VIDED.
Feb 17 2017 Brief amicus curiae of America's Insurance Health Plans filed. VIDED.
Feb 17 2017 Brief amicus curiae of United States filed. VIDED.
Feb 17 2017 Brief amicus curiae of Biosimilars Council filed. VIDED.
Feb 17 2017 Brief amicus curiae of Mylan Inc. filed. VIDED.
Feb 21 2017 Motion to dispense with printing the joint appendix filed by petitioners GRANTED. VIDED.
Feb 24 2017 Record requested from the U.S.C.A. for the Federal Circuit. VIDED.
Mar 10 2017 Opening and Response Brief for Amgen Inc., et al. filed. VIDED.
Mar 17 2017 Brief amicus curiae of AbbVie Inc. filed. VIDED.
Mar 17 2017 Motion of the Acting Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument filed. VIDED.
Mar 17 2017 Brief amici curiae of Eleven Professors filed.
Mar 17 2017 Brief amicus curiae of Janssen Biotech, Inc. filed. VIDED.
Mar 17 2017 Brief amicus curiae of Biotechnology Innovation Organization. filed. VIDED.
Mar 17 2017 Brief amicus curiae of Genentech, Inc. filed. VIDED.
Mar 22 2017 CIRCULATED.
Mar 27 2017 Record received from the U.S.C.A. for the Federal Circuit. The record is available on PACER, except for confidential materials transmitted separately. VIDED.
Mar 31 2017 Consolidated Response and Reply Brief of Sandoz Inc. filed. VIDED. (Distributed)
Apr 13 2017 Motion of the Acting Solicitor General for leave to participate in oral argument as amici curiae and for divided argument GRANTED. VIDED. Justice Gorsuch too no part in the consideration or decision of this motion.
Apr 13 2017 Reply of petitioners Amgen Inc., et al. filed. (Distributed)
Apr 26 2017 Argued. For petitioner in No. 15-1039: Deanne E. Maynard, Washington, D. C.; and Anthony A. Yang, Assistant to the Solicitor General, Department of Justice, Washington, D. C. (for United States, as amicus curiae.) For petitioners in 15-1195: Seth P. Waxman, Washington, D. C. VIDED.
Jun 12 2017 Adjudged to be VACATED IN PART, REVERSED IN PART, and case REMANDED. Thomas, J., delivered the opinion for a unanimous Court. Breyer, J., filed a concurring opinion. VIDED.



~~Name~~~~~~~~~~~~~~~~~~~~~    ~~~~~~~Address~~~~~~~~~~~~~~~~~~   ~~Phone~~~
Attorneys for Petitioners:
Seth P. Waxman Wilmer Cutler Pickering Hale and Dorr LLP(202) 663-6000
    Counsel of Record1875 Pennsylvania Avenue, N.W.
Washington, DC  20006
seth.waxman@wilmerhale.com
Party name: Amgen Inc., et al.
 
Nicholas Groombridge Paul, Weiss, Rifkind, Wharton & Garrison, LLP(212) 373-3000
1285 Avenue of the Americas
New York, NY  10019-6064
ngroombridge@paulweiss.com
Party name: Amgen Inc., et al.
Attorneys for Respondent:
Deanne E. Maynard Morrison & Foerster LLP(202) 887-8740
    Counsel of Record2000 Pennsylvania Avenue, N.W.
Washington, DC  20006
DMaynard@mofo.com
Party name: Sandoz Inc.
Other:
Carlos T. Angulo Zuckerman Spaeder LLP(202) 778-1800
1800 M St., N.W., Suite 100
Washington, DC  20036
cangulo@zuckerman.com
Party name: America's Insurance Health Plans.
 
Craig E. Countryman Fish & Richardson, P.C.(858) 678-5070
12390 El Camino Real
San Diego, CA  92130
countryman@fr.com
Party name: Coherus Biosciences, Inc.
 
Gregory L. Diskant Patterson Belknap Webb & Tyler LLP(212) 336-2000
1133 Avenue of the Americas
New York, NY  10036
gldiskant@pbwt.com
Party name: Janssen Biotech, Inc.
 
David C. Frederick Kellogg, Huber, Hansen, Todd, Evans & Figel, P.L.L.C.(202) 326-7900
1615 M Street, N.W., Suite 400
Washington, DC  20036
dfrederick@kellogghansen.com
Party name: Apotex Inc. and Apotex Corp.
 
William M. Jay Goodwin Procter LLP(202) 346-4190
901 New York Avenue, N.W.
Washington, DC  20001
wjay@goodwinlaw.com
Party name: Biosimilars Council
 
Kevin E. Noonan McDonnell Boehnen Hulbert & Berghoff, LLP(312) 913-0001
300 South Wacker Drive
Chicago, IL  60606
noonan@mbhb.com
Party name: Eleven Professors
 
William A. Rakoczy Racoczy Molino Mazzochi Siwik LLP(312) 527-2157
6 West Hubbard Street,
Suite 500
Chicago, IL  60654
wrakoczy@rmmslegal.com
Party name: Mylan Inc.
 
E. Joshua Rosenkranz Orrick, Herrington & Sutcliffe LLP(212) 506-5000
51 West 52nd Street
New York, NY  10019-6142
jrosenkranz@orrick.com
Party name: Genentech, Inc.
 
Melissa Arbus Sherry Latham & Watkins LLP(202) 637-2200
555 Eleventh Street, NW, Suite 1000
Washington, DC  20004
melissa.sherry@lw.com
Party name: AbbVie Inc..
 
Jeffrey B. Wall Acting Solicitor General(202) 514-2217
United States Department of Justice
950 Pennsylvania Avenue, N.W.
Washington, DC  20530-0001
SupremeCtBriefs@USDOJ.gov
Party name: United States
 
Donald R. Ware Foley Hoag LLP(617) 832-1000
155 Seaport Boulevard
Boston, MA  02210
drw@foleyhoag.com
Party name: Biotechnology Innovation Organization
 
Anthony Alan Yang Office of the Solicitor General (202)-514-4821
950 Pennsylvania Ave.NW
Room 5615
Washington, DC  20530-0001
Party name: United States
June 23, 2017 | Version 2014.2